Australia markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1200+0.1300 (+3.37%)
As of 01:00PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
4,470
9,158
2,778
6,546
21,870
-
Selling general and administrative
9,306
6,728
8,640
8,752
7,846
-
Total operating expenses
13,776
15,886
11,418
15,298
29,716
-
Operating income or loss
-13,776
-15,886
-11,418
-15,298
-29,716
-
Interest expense
-
0
2,191
0
-
-
Total other income/expenses net
2,969
2,955
-358
-
-1
-1,114
Income before tax
-13,869
-12,470
-13,967
-15,284
-29,678
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-13,869
-12,470
-13,967
-15,284
-29,678
-
Net income
-13,869
-12,470
-13,967
-15,284
-29,678
-
Net income available to common shareholders
-13,869
-12,470
-13,967
-15,284
-29,678
-
Basic EPS
-43.82
-2.46
-43.42
-158.48
-439.20
-
Diluted EPS
-43.82
-2.46
-43.42
-158.48
-439.20
-
Basic average shares
3,826
5,071
321.703
96.427
67.572
-
Diluted average shares
3,826
5,071
321.703
96.427
67.572
-